Bioavailability of Plant Protein Amino Acids

NCT ID: NCT04872530

Last Updated: 2023-11-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-01-08

Study Completion Date

2023-09-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to inform of the mechanism of action of plant-based protein by measuring the bioavailability (i.e. rate of appearance and magnitude of concentration in the circulation following oral ingestion) of key amino acid and metabolic products that regulate skeletal muscle protein synthesis (MPS) in humans.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Plant-based proteins contain several amino acids that are essential to signal muscle growth/repair and act as a substrate during muscle protein synthesis. However, compared to animal protein or free-amino acids, the bioavailability of certain essential amino acids may be compromised. Following selective processing (e.g. removal of carbohydrate and/or other anti-nutritive factors) food grade plant-based protein concentrates possibly confer greater bioavailability and bioactivity in vivo. This project explores the bioavailability and bioactivity of selected plant-based protein concentrates following oral ingestion in young, healthy men and women.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bioavailability of Amino Acids Following Oral Ingestion of Plant-Based Proteins in Young, Healthy Men

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Bioavailability of Amino Acids Following Oral Ingestion of Plant-Based Proteins in Young, Healthy Men

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Subjects who volunteer for this study will undertake SIX controlled feeding trials, each trial separated by 7 days.Subjects will be assigned to a randomised sequence of six protein isolates including: (1) pea-protein concentrate; (2) fava-bean protein concentrate; (3) chickpea protein concentrate; (4) red lentil protein concentrate; (5) non-essential amino acid blend (negative control);( 6) whey protein concentrate. Protein is dosed at 0.33 g/kg body mass in 500 ml of water.
Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pea-protein concentrate

Pea-protein concentrate dosed at 0.33 g/kg body mass in 500 ml of water.

Group Type EXPERIMENTAL

Pea-protein concentrate

Intervention Type DIETARY_SUPPLEMENT

Pea-protein concentrate

Fava-bean protein concentrate

Fava-bean protein concentrate dosed at 0.33 g/kg body mass in 500 ml of water.

Group Type EXPERIMENTAL

Fava-bean protein concentrate

Intervention Type DIETARY_SUPPLEMENT

Fava-bean protein concentrate

Chickpea protein concentrate

Chickpea protein concentrate dosed at 0.33 g/kg body mass in 500 ml of water.

Group Type EXPERIMENTAL

Chickpea protein concentrate

Intervention Type DIETARY_SUPPLEMENT

Chickpea protein concentrate

Red lentil protein concentrate

Red lentil protein concentrate dosed at 0.33 g/kg body mass in 500 ml of water.

Group Type EXPERIMENTAL

Red lentil protein concentrate

Intervention Type DIETARY_SUPPLEMENT

Red lentil protein concentrate

Non-essential amino acid blend

Non-essential amino acid blend dosed at 0.33 g/kg body mass in 500 ml of water.

Group Type EXPERIMENTAL

Non-essential amino acid blend

Intervention Type DIETARY_SUPPLEMENT

Non-essential amino acid blend

Whey protein concentrate

Whey protein concentrate dosed at 0.33 g/kg body mass in 500 ml of water.

Group Type EXPERIMENTAL

Whey protein concentrate

Intervention Type DIETARY_SUPPLEMENT

Whey protein concentrate

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pea-protein concentrate

Pea-protein concentrate

Intervention Type DIETARY_SUPPLEMENT

Fava-bean protein concentrate

Fava-bean protein concentrate

Intervention Type DIETARY_SUPPLEMENT

Chickpea protein concentrate

Chickpea protein concentrate

Intervention Type DIETARY_SUPPLEMENT

Red lentil protein concentrate

Red lentil protein concentrate

Intervention Type DIETARY_SUPPLEMENT

Non-essential amino acid blend

Non-essential amino acid blend

Intervention Type DIETARY_SUPPLEMENT

Whey protein concentrate

Whey protein concentrate

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* No known intolerance to any item contained in the protein products.
* No blood borne disease risk, current illness or medication that would adversely affect participation
* No known adverse reaction to venepuncture

Exclusion Criteria

* n/a
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Marigot Ltd.

INDUSTRY

Sponsor Role collaborator

Enterprise Ireland

OTHER_GOV

Sponsor Role collaborator

University of Limerick

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Phil Jakeman, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Limerick

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Education and Health Sciences

Limerick, , Ireland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Ireland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2019_12_02_EHS

Identifier Type: -

Identifier Source: org_study_id